Eli Lilly and Co

Currency traders work near screens showing the Korea Composite Stock Price Index (KOSPI), left, and the foreign exchange rate between U.S. dollar and South Korean won at a bank's foreign exchange dealing room in Seoul, South Korea, Monday, May 3, 2021. Shares were mostly lower in Asia in thin trading Monday, with many markets including those in Tokyo and Shanghai closed for holidays. (AP Photo/Lee Jin-man)

Wall Street opening higher Monday on strong earnings

By Elaine Kurtenbach May. 03, 2021 02:26 AM EDT

A currency trader walks by a screen showing the Korea Composite Stock Price Index (KOSPI) at a bank's foreign exchange dealing room in Seoul, South Korea, Monday, May 3, 2021. Shares were mostly lower in Asia in thin trading Monday, with many markets including those in Tokyo and Shanghai closed for holidays. (AP Photo/Lee Jin-man)

Asian shares mostly lower; China, Japan closed for holidays

By Elaine Kurtenbach May. 02, 2021 11:41 PM EDT

FILE - In this March 23, 2021 file photo, pedestrians walk past the New York Stock Exchange in New York's Financial District. Stocks are pulling back in the early going on Wall Street, easing the S&P 500 below the record high it set a day earlier. The index is still on track to close out its third solid monthly gain in a row. It was down 0.5% in the first few minutes of trading Friday, April 30, and technology and communications stocks were doing the most damage. (AP Photo/Mary Altaffer, File)

Stocks pull below record but still end best month this year

By Damian J. Troise And Alex Veiga Apr. 30, 2021 01:43 AM EDT

FILE- In this May 19, 2020 file photo, a chemist displays hydroxychloroquine tablets in Mumbai, India. With India’s surge exploding, people are resorting to medical treatments that have not been approved internationally for COVID-19, causing shortages and booming black markets. Drugs such as hydroxychloroquine, which the WHO has strongly recommended not be used for coronavirus, are being used by desperate patients. (AP Photo/Rafiq Maqbool, File)

Indians turn to black market, unproven drugs as virus surges

By Aniruddha Ghosal And Neha Mehrotra Apr. 29, 2021 06:47 AM EDT

Priscilla Medina stands with her husband, Jason Sanchez, and her son in the Rego Park neighborhood of Queens in New York on Wednesday, April 7, 2021. If Medina had gotten COVID-19 a year earlier, she would have had no treatments proven safe and effective to try. But when the 30-year-old nurse arrived at a Long Island hospital in March 2021, so short of breath she could barely talk, doctors knew just what to do. They quickly arranged for her to get a novel drug that supplies virus-blocking antibodies, and “by the next day I was able to get up and move around,” she said. After two days, “I really started turning the corner. I was showering, eating, playing with my son.” (AP Photo/Marshall Ritzel)

COVID treatment has improved, but many wish for an easy pill

By Marilynn Marchione Apr. 26, 2021 10:24 AM EDT

Proposed Indiana voting law change faces corporate criticism

By Tom Davies Apr. 06, 2021 12:10 PM EDT
INDIANAPOLIS (AP) — One of Indiana’s most prominent corporations is criticizing an Indiana proposal that opponents maintain will make mail-in voting more...

Chevron, Johnson & Johnson fall; Novavax, Skyworks rise

Jan. 29, 2021 04:15 PM EST
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday: Novavax Inc., up $86.93 to $220.94. ...

FILE- In this April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly’s new COVID-19 treatment helped the drugmaker’s fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter. The antibody treatment bamlanivimab brought in $871 million in sales for Lilly after the Food and Drug Administration authorized emergency use in November 2020 for patients with mild-to-moderate COVID-19. . (AP Photo/Darron Cummings, File)

Lilly 4Q profit surges, helped by new COVID-19 treatment

By Tom Murphy Jan. 29, 2021 08:33 AM EST

FILE - This April 26, 2017 file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Drugmaker Eli Lilly said Thursday, Jan. 21, 2021, its COVID-19 antibody drug can prevent illness among residents and staff of nursing homes and other long-term care locations. It’s the first major study to show that it may prevent disease. The drugmaker said participants who got the drug had up to a 57% lower risk of getting COVID-19. (AP Photo/Darron Cummings, File)

Lilly: Drug can prevent COVID-19 illness in nursing homes

By Tom Murphy Jan. 21, 2021 08:51 AM EST

A woman wearing a face mask to protect against coronavirus walks at a train station in Moscow, Russia, Monday, Jan. 11, 2021. (AP Photo/Pavel Golovkin)

The Latest: New Zealand visitors must show negative test

By The Associated Press Jan. 11, 2021 02:31 AM EST

Tucson hospital launches center for virus antibody treatment

Jan. 07, 2021 11:04 PM EST
TUCSON, Ariz. (AP) — Federal health officials are teaming up with a Tucson hospital to provide COVID-19 medicines that may help keep infected people out of the...

In this Saturday, March, 14, 2020 photo provided by Regeneron, , left, and members of the company's infectious disease team pose for a photo as they celebrate their first discovery of potential antibodies to treat COVID-19. They had spent weeks drawing blood from early survivors across the globe and from mice with human-like immune systems - all to test thousands of potential treatments. (Regeneron via AP)

One company's quest for an antibody drug to fight COVID-19

By Marilynn Marchione Dec. 21, 2020 12:05 AM EST

Guest lineups for the Sunday news shows

Dec. 18, 2020 06:16 PM EST
WASHINGTON (AP) — Guest lineups for the Sunday news shows: ABC’s “This Week” — Sen. Mark Warner, D-Va.; Adm. Brett Giroir, the Health and...